Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 USD | +3.06% | +2.79% | -26.36% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Chief Tech/Sci/R&D Officer | 51 | 18-10-22 | |
Chief Administrative Officer | - | 15-08-31 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 20-12-31 |
Nadia Agopyan
LAW | General Counsel | 62 | 19-08-14 |
General Counsel | 67 | 18-10-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 18-10-16 |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,919,095 | 7,830,643 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.36% | 35.03M | |
+47.26% | 58.71B | |
-3.54% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.17% | 26.55B | |
-22.88% | 18.98B | |
+1.41% | 12.51B | |
+25.30% | 12.08B | |
+21.85% | 11.94B |
- Stock Market
- Equities
- MRKR Stock
- Company Marker Therapeutics, Inc.